Clinical Trial Update: Prevention of Thromboembolism Using Apixaban vs Enoxaparin Following Spinal Cord Injury [NA]

View source ↗

Summary

This clinical trial update indicates an ongoing study comparing apixaban to enoxaparin for prevention of thromboembolism after spinal cord injury. The study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• Eliquis (apixaban)
• Lovenox (enoxaparin)

Snippet

Sponsor: Loewenstein Hospital | Conditions: Spinal Cord Injuries, Spinal Diseases | NA | Status: RECRUITING